Orange Book product
CARBIDOPA AND LEVODOPA 50MG;200MG
Orange Book ANDA 076521 · IMPAX LABORATORIES INC · Prescription
Key facts
| Proprietary name | CARBIDOPA AND LEVODOPA |
|---|---|
| Active ingredients | CARBIDOPA, LEVODOPA |
| Strength | 50MG;200MG |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Application | ANDA076521 |
| Applicant holder | IMPAX LABORATORIES INC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AB |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | May 14, 2004 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.